Limits...
Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.

Demment MM, Peters K, Dykens JA, Dozier A, Nawaz H, McIntosh S, Smith JS, Sy A, Irwin T, Fogg TT, Khaliq M, Blumenfeld R, Massoudi M, De Ver Dye T - PLoS ONE (2015)

Bottom Line: We conducted a scoping study based on the six-stage framework of Arskey and O'Malley.Most reviews did not include elements of the PRISMA checklist.Further breast and cervical cancer prevention and control studies are necessary in LMICs.

View Article: PubMed Central - PubMed

Affiliation: Clinical and Translational Research Institute, University of Rochester, Rochester, New York, United States of America.

ABSTRACT

Background: Breast and cervical cancers have emerged as major global health challenges and disproportionately lead to excess morbidity and mortality in low- and middle-income countries (LMICs) when compared to high-income countries. The objective of this paper was to highlight key findings, recommendations, and gaps in research and practice identified through a scoping study of recent reviews in breast and cervical cancer in LMICs.

Methods: We conducted a scoping study based on the six-stage framework of Arskey and O'Malley. We searched PubMed, Cochrane Reviews, and CINAHL with the following inclusion criteria: 1) published between 2005-February 2015, 2) focused on breast or cervical cancer 3) focused on LMIC, 4) review article, and 5) published in English.

Results: Through our systematic search, 63 out of the 94 identified cervical cancer reviews met our selection criteria and 36 of the 54 in breast cancer. Cervical cancer reviews were more likely to focus upon prevention and screening, while breast cancer reviews were more likely to focus upon treatment and survivorship. Few of the breast cancer reviews referenced research and data from LMICs themselves; cervical cancer reviews were more likely to do so. Most reviews did not include elements of the PRISMA checklist.

Conclusion: Overall, a limited evidence base supports breast and cervical cancer control in LMICs. Further breast and cervical cancer prevention and control studies are necessary in LMICs.

No MeSH data available.


Related in: MedlinePlus

PRISMA flow diagram for review of manuscripts.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4556679&req=5

pone.0134618.g001: PRISMA flow diagram for review of manuscripts.

Mentions: The search strategy implemented resulted in 62 reviews of cervical cancer and 34 reviews of breast cancer in LMIC settings that met our eligibility criteria (Fig 1). Cervical and breast cancer reviews differed substantially (Table 2). The cervical cancer literature reflected a substantially larger volume and distribution of both systematic [14, 23–40] and non-systematic reviews [12, 41–80], while the breast cancer literature predominantly consisted of consensus statements [81–102], with fewer systematic [103–108] or non-systematic [109–115] reviews. The cervical cancer literature also contained three consensus statements [116–118].


Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.

Demment MM, Peters K, Dykens JA, Dozier A, Nawaz H, McIntosh S, Smith JS, Sy A, Irwin T, Fogg TT, Khaliq M, Blumenfeld R, Massoudi M, De Ver Dye T - PLoS ONE (2015)

PRISMA flow diagram for review of manuscripts.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4556679&req=5

pone.0134618.g001: PRISMA flow diagram for review of manuscripts.
Mentions: The search strategy implemented resulted in 62 reviews of cervical cancer and 34 reviews of breast cancer in LMIC settings that met our eligibility criteria (Fig 1). Cervical and breast cancer reviews differed substantially (Table 2). The cervical cancer literature reflected a substantially larger volume and distribution of both systematic [14, 23–40] and non-systematic reviews [12, 41–80], while the breast cancer literature predominantly consisted of consensus statements [81–102], with fewer systematic [103–108] or non-systematic [109–115] reviews. The cervical cancer literature also contained three consensus statements [116–118].

Bottom Line: We conducted a scoping study based on the six-stage framework of Arskey and O'Malley.Most reviews did not include elements of the PRISMA checklist.Further breast and cervical cancer prevention and control studies are necessary in LMICs.

View Article: PubMed Central - PubMed

Affiliation: Clinical and Translational Research Institute, University of Rochester, Rochester, New York, United States of America.

ABSTRACT

Background: Breast and cervical cancers have emerged as major global health challenges and disproportionately lead to excess morbidity and mortality in low- and middle-income countries (LMICs) when compared to high-income countries. The objective of this paper was to highlight key findings, recommendations, and gaps in research and practice identified through a scoping study of recent reviews in breast and cervical cancer in LMICs.

Methods: We conducted a scoping study based on the six-stage framework of Arskey and O'Malley. We searched PubMed, Cochrane Reviews, and CINAHL with the following inclusion criteria: 1) published between 2005-February 2015, 2) focused on breast or cervical cancer 3) focused on LMIC, 4) review article, and 5) published in English.

Results: Through our systematic search, 63 out of the 94 identified cervical cancer reviews met our selection criteria and 36 of the 54 in breast cancer. Cervical cancer reviews were more likely to focus upon prevention and screening, while breast cancer reviews were more likely to focus upon treatment and survivorship. Few of the breast cancer reviews referenced research and data from LMICs themselves; cervical cancer reviews were more likely to do so. Most reviews did not include elements of the PRISMA checklist.

Conclusion: Overall, a limited evidence base supports breast and cervical cancer control in LMICs. Further breast and cervical cancer prevention and control studies are necessary in LMICs.

No MeSH data available.


Related in: MedlinePlus